HLA-Cw*04 and hepatitis C virus persistence
- PMID: 11967296
- PMCID: PMC136132
- DOI: 10.1128/jvi.76.10.4792-4797.2002
HLA-Cw*04 and hepatitis C virus persistence
Abstract
In studies of acute hepatitis C virus (HCV) infection, the early host immune response is one of the determinants of viral persistence. The class I human leukocyte antigens (HLA), which present foreign antigen to cytolytic T cells, are integral components of this response. We hypothesized that the highly polymorphic HLA genes affect the outcome of an HCV infection. To test this hypothesis, we molecularly typed 231 persons with well-documented clearance of an HCV infection and 444 matched persistently infected persons. HLA-A*1101 (odds ratio [OR], 0.49; 95% confidence interval [95% CI], 0.27 to 0.89), HLA-B*57 (OR, 0.62; 95% CI, 0.39 to 1.00), and HLA-Cw*0102 (OR, 0.43; 95% CI, 0.21 to 0.89) were associated with viral clearance, whereas HLA-A*2301 (OR, 1.78; 95% CI, 1.01 to 3.11) and HLA-Cw*04 (OR, 1.78; 95% CI, 1.21 to 2.59) were associated with viral persistence. HLA-Cw*04 is in strong linkage disequilibrium with HLA-B*53 and HLA-B*35, but only HLA-B*53 (OR, 1.70; 95% CI, 0.95 to 3.06) and the Cw*04-B*53 haplotype (OR, 1.76; 95% CI, 0.94 to 3.26) were weakly associated with viral persistence. HLA-B*53 has similar, but not necessarily identical, binding specificity to some HLA-B*35 subtypes (B*35-Px group). The association with the B*35-Px group was less strong than with HLA-B*53 alone. The association of HLA-Cw*04 with HCV persistence was codominant (two copies of the gene were more strongly associated with persistence than one copy). However, HLA-Cw*04 was not associated with HCV RNA levels among the persistently infected individuals. Since Cw*04 is a ligand for the killer immunoglobulin-like receptors on natural killer cells, these cells may be involved in recovery from HCV infection. Further investigation is needed to understand the relationship between class I alleles and HCV clearance.
Similar articles
-
Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II.Viral Immunol. 2007 Summer;20(2):312-9. doi: 10.1089/vim.2006.0060. Viral Immunol. 2007. PMID: 17603847
-
Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1.Hum Immunol. 2004 Jul;65(7):745-51. doi: 10.1016/j.humimm.2004.05.001. Hum Immunol. 2004. PMID: 15301865
-
Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source.Hepatology. 2004 Jul;40(1):108-14. doi: 10.1002/hep.20261. Hepatology. 2004. PMID: 15239092
-
Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome.Mol Immunol. 2008 May;45(9):2429-36. doi: 10.1016/j.molimm.2008.01.002. Epub 2008 Mar 4. Mol Immunol. 2008. PMID: 18289678 Free PMC article. Review.
-
A comparative review of HLA associations with hepatitis B and C viral infections across global populations.World J Gastroenterol. 2007 Mar 28;13(12):1770-87. doi: 10.3748/wjg.v13.i12.1770. World J Gastroenterol. 2007. PMID: 17465466 Free PMC article. Review.
Cited by
-
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.Microorganisms. 2024 May 21;12(6):1035. doi: 10.3390/microorganisms12061035. Microorganisms. 2024. PMID: 38930417 Free PMC article. Review.
-
Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle.Gastroenterology. 2010 Apr;138(4):1240-3. doi: 10.1053/j.gastro.2010.02.033. Epub 2010 Feb 23. Gastroenterology. 2010. PMID: 20184973 Free PMC article. No abstract available.
-
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.Can J Gastroenterol. 2007 Jul;21(7):447-51. doi: 10.1155/2007/796325. Can J Gastroenterol. 2007. PMID: 17637948 Free PMC article.
-
HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance.Front Immunol. 2015 Oct 29;6:552. doi: 10.3389/fimmu.2015.00552. eCollection 2015. Front Immunol. 2015. PMID: 26579127 Free PMC article.
-
Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Virology (Auckl). 2013 Feb 11;4:1-25. doi: 10.4137/VRT.S11046. eCollection 2013. Virology (Auckl). 2013. PMID: 25512691 Free PMC article. Review.
References
-
- Anonymous. 1997. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 26:2S-10S. - PubMed
-
- Barber, L. D., B. Gillece-Castro, L. Percival, X. Li, C. Clayberger, and P. Parham. 1995. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr. Biol. 5:179-190. - PubMed
-
- Barrett, S., E. Ryan, and J. Crowe. 1999. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J. Hepatol. 30:979-983. - PubMed
-
- Carrington, M., G. W. Nelson, M. P. Martin, T. Kissner, D. Vlahov, J. J. Goedert, R. Kaslow, S. Buchbinder, K. Hoots, and S. J. O'Brien. 1999. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283:1748-1752. - PubMed
-
- Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661-671. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K08 DA000441/DA/NIDA NIH HHS/United States
- DA00441/DA/NIDA NIH HHS/United States
- N01-CP-33002/CP/NCI NIH HHS/United States
- R37 DA004334/DA/NIDA NIH HHS/United States
- N01-CO-56000/CO/NCI NIH HHS/United States
- M01-RR02558/RR/NCRR NIH HHS/United States
- R56 DA004334/DA/NIDA NIH HHS/United States
- R01 DA013324/DA/NIDA NIH HHS/United States
- R01 DA004334/DA/NIDA NIH HHS/United States
- M01-RR00071/RR/NCRR NIH HHS/United States
- DA04334/DA/NIDA NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- M01 RR000059/RR/NCRR NIH HHS/United States
- M01-RR00059/RR/NCRR NIH HHS/United States
- DA13324/DA/NIDA NIH HHS/United States
- N01-HD-4-3200/HD/NICHD NIH HHS/United States
- M01 RR002558/RR/NCRR NIH HHS/United States
- M01-RR06020/RR/NCRR NIH HHS/United States
- MCJ-060570/PHS HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials